EGFR and lung carcinoma: The elevated expression of CD109 was found to promote tumour metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signalling pathways and aggressiveness of cervical squamous cell carcinoma with the EGFR regulation [25,26,27,28,29].